{
  "id": "15d90c8fa53a6715",
  "title": "SpyGlass Pharma Announces First Patients Randomized in SGP - 005 and SGP - 006 , Two Registrational Phase III Clinical Trials of Its Novel BIM - IOL System",
  "description": "20260120T140000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/spyglass-pharma-announces-first-patients-randomized-in-sgp-005-and-sgp-006-two-registrational-phase-iii-clinical-trials-of-its-novel-bim-iol-system/2261783",
  "published_at": "20260120T140000Z",
  "fetched_at": "2026-01-21T00:24:36.527019+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/spyglass-pharma-announces-first-patients-randomized-in-sgp-005-and-sgp-006-two-registrational-phase-iii-clinical-trials-of-its-novel-bim-iol-system/2261783",
    "url_mobile": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/spyglass-pharma-announces-first-patients-randomized-in-sgp-005-and-sgp-006-two-registrational-phase-iii-clinical-trials-of-its-novel-bim-iol-system/2261783/amp",
    "title": "SpyGlass Pharma Announces First Patients Randomized in SGP - 005 and SGP - 006 , Two Registrational Phase III Clinical Trials of Its Novel BIM - IOL System",
    "seendate": "20260120T140000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/20/905971.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}